Amarin Co. plc (NASDAQ:AMRN) was downgraded by analysts at Leerink Swann from an “outperform” rating to a “market perform” rating in a research report issued to clients and investors on Wednesday, TheFlyOnTheWall.com reports.
Amarin Co. plc (NASDAQ:AMRN) opened at 2.095 on Wednesday. Amarin Co. plc has a one year low of $5.12 and a one year high of $14.30. The stock has a 50-day moving average of $6.03 and a 200-day moving average of $6.69. The company’s market cap is $361.6 million.
Amarin Co. plc (NASDAQ:AMRN) last released its earnings data on Thursday, August 8th. The company reported ($0.26) earnings per share for the quarter, beating the analysts’ consensus estimate of ($0.38) by $0.12. The company had revenue of $5.50 million for the quarter. On average, analysts predict that Amarin Co. plc will post $-1.35 earnings per share for the current fiscal year.
A number of other firms have also recently commented on AMRN. Analysts at FBR Capital Markets initiated coverage on shares of Amarin Co. plc in a research note to investors on Wednesday. They set a “market perform” rating and a $2.00 price target on the stock. Separately, analysts at Citigroup Inc. downgraded shares of Amarin Co. plc to a “neutral” rating in a research note to investors on Friday, October 18th. Finally, analysts at Citigroup Inc. downgraded shares of Amarin Co. plc from a “buy” rating to a “neutral” rating in a research note to investors on Friday, October 18th. They now have a $2.50 price target on the stock, down previously from $11.00. Eleven analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. The company currently has an average rating of “Hold” and an average price target of $8.54.
Amarin Corporation plc (NASDAQ:AMRN) is a late-stage biopharmaceutical -company with expertise in lipid science focused on the treatment of cardiovascular disease.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.